Regardless of the underlying mechanisms, the suppressed compaction of blood clots may be an important pathogenic mechanism for hemostatic disorders with a bleeding tendency in diseases associated with the MYH9 gene mutation. This evidence concerns the gene MYH9 and vascular hemostatic disease.